Advertisement

Abstract

Since the introduction of the carrier concept by Osterhout in 1935 [8] this notion has been used in the discussion of biological transport phenomena in increasing measure. This is mainly due to two types of observations: 1. pronounced structural specificity of penetration, resembling in many cases the stereo-specificity of enzymatic reaction and indicating an essential role of chemical reactivity; 2. observations pointing to a limited transport capacity, i.e. saturation kinetics and competition.

Keywords

Perfuse Heart Saturation Kinetic Induce Movement Carrier Mechanism Biological Transport 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Adrian, R. H., 1962: Symp. on The Plasma Membrane, Suppl. to Circulation 26, 1214–1223.Google Scholar
  2. [2]
    Crofford, O. B., and A. E. Renold, 1965: J. Biol, Chem. 249, 3237–3244.Google Scholar
  3. [3]
    Keynes, R. D.: This symposium.Google Scholar
  4. [4]
    Fisher, R. B., 1961: In: “Enzymes and Drug Action,” Ciba Foundation Symp. (J. L. Mongar and A. V. S. de Reuck, editors) p. 83–94.Google Scholar
  5. [5]
    LeFevre, P. G., 1955: Protoplasmatologia VIII/7 A, 1–123.Google Scholar
  6. [6]
    Morgan, H. E., M. J. Henderson, D. M. Regen, and C. R. Park, 1961: J. Biol. Chem. 236, 253–261.PubMedGoogle Scholar
  7. [7]
    Müller, P., 1965: J. Physiol. 177, 453–462.Google Scholar
  8. [8]
    Osternout, W. J. V., 1935: Proc. Nat. Acad. Sci., U.S. 21, 125–132.CrossRefGoogle Scholar
  9. [9]
    Rosenberg, T., and W. Wilbrandt, 1957: J. Gen. Physiol. 41, 289–296.PubMedCrossRefGoogle Scholar
  10. [10]
    Rosenberg, T., and W. Wilbrandt, 1963: J. Theoret. Biol. 5, 288–305.CrossRefGoogle Scholar
  11. [11]
    Shaw, T. L. 1954: Ph. D.-Thesis, Cambridge University, England 1954 (quoted from Glynn, Progress Biophys. 8, 241–307, 1957).Google Scholar
  12. [12]
    Solomon, A. K., 1952/53: J. Gen. Physiol. 36, 57–110.PubMedCrossRefGoogle Scholar
  13. [13]
    Stein, W. D.: Discussion remark at this symposium1.Google Scholar
  14. [14]
    Widdas, W. F., 1952: J. Physiol. 118, 23–39.PubMedGoogle Scholar
  15. [15]
    Widdas, W. F., 1954: J. Physiol. 125, 163–180.PubMedGoogle Scholar
  16. [16]
    Wilbrandt, W., 1954: Symp. Soc. exp. Biol. 8, 136–162.Google Scholar
  17. [17]
    Wilbrandt, W., 1956: J. cell. comp. Physiol. 47, 137–145.CrossRefGoogle Scholar
  18. [18]
    Wilbrandt, W., 1965: Folia Haematologica, p. 5–13.Google Scholar
  19. [19]
    Wilbrandt, W., et al.: Unpublished data.Google Scholar
  20. [20]
    Wilbrandt, W., S. Frei, and T. Rosenberg, 1956: Exper. Cell Res. 11, 59–66.CrossRefGoogle Scholar
  21. [21]
    Wilbrandt, W., and A. Kotyk, 1964: Arch. exp. Path. Pharm. 249, 279–287.CrossRefGoogle Scholar
  22. [22]
    Wilbrandt, W., and T. Rosenberg, 1961: Pharmacol. Rev. 13, 109–183.PubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1967

Authors and Affiliations

  • W. Wilbrandt
    • 1
  1. 1.Department of PharmacologyUniversity of BerneSwitzerland

Personalised recommendations